Clinical Trials Logo

Clinical Trial Summary

This study focuses on patients with a primary complaint of hyperacusis. Hyperacusis has been defined as 'abnormally reduced tolerance to sound' and is commonly associated with tinnitus. The effects of somatic modulation upon tinnitus have been studied, but not so for hyperacusis.. The effect of 9 somatic modulations (i.e. 3 jaw modulations and 6 cervical spine modulations) and 1 control movement (i.e. without any somatic modulation effect) in random order on the sound tolerance of a 1 kilohertz (kHz) broadband noise sound and the tinnitus experience will be investigated. More specifically, the perceived loudness and intrusiveness of this sound and the tinnitus sound will be evaluated before somatic modulation and during the somatic modulation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04693819
Study type Observational
Source University Hospital, Antwerp
Contact
Status Completed
Phase
Start date December 7, 2020
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT03206996 - Exposure Therapy for Auditory Sensitivity in Autism N/A
Recruiting NCT04752176 - Evaluation of the Elimination of Tinnitus and Hyperacusis by the ØREBLUE® Method
Active, not recruiting NCT00730834 - Customized Acoustic Stimulation for Long Term Medical Benefit for the Relief of Tinnitus and Hyperacusis Phase 4
Completed NCT00486577 - Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus Phase 2/Phase 3
Completed NCT01321814 - Cognitive Behavioral Therapy for Hyperacusis N/A
Completed NCT00890526 - Intervention for Reduced Sound Tolerance Phase 1
Not yet recruiting NCT04705246 - Role of Exposure in Hyperacusis N/A
Recruiting NCT05976789 - A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis N/A
Not yet recruiting NCT04934371 - Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy N/A